Analyst Moves: SRPT, NKE

Home › Analyst Moves: SRPT, NKE

Sarepta was initiated with a rating of buy at Deutsche Bank as its muscular dystrophy drug will drive growth during the next several quarters.

26.11	Sports service SPOTV adopts Zixi for affiliate delivery
26.11	EQT to sell Melita to Goldman Sachs Alternatives
26.11	U.S. spending on standalone pay TV increased in Q3 2024
26.11	DIRECTV terminates agreement to acquire EchoStar's DISH
26.11	Xumo and PubMatic partner on programmatic advertising
26.11	Vauxhall owner to close Luton plant
26.11	Adara solves PowerKEY CA time-out issue for Aster Tecnodisa
26.11	Mediaocean to acquire Innovid
Consumer Goods and Services »

je.st